US 10202452
CD3 binding polypeptides
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 10202452 (CD3 binding polypeptides) held by Aptevo Research and Development LLC expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aptevo Research and Development LLC
- Grant date
- Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61P, A61P35/00